Rapid Communication Hospital and Outpatient Health Services Utilization Among HIV‐Infected Patients in Care in 1999
暂无分享,去创建一个
Richard D Moore | J. Fleishman | R. Conviser | P. Gaist | K. Gebo | V. Sharp | J. Keruly | M. Gourevitch | G. Kalkut | P. Keiser | F. Hellinger | J. Nadler | R. Rutstein | J. Dilonardo | J. Hellinger | S. Fine | Marla Gold | Ming-yao Zhao | E. Reilly | B. Goldberg | P. Nemechek | J. Jovanovich | L. Crane | Kathye Gorosh | J. Post | R. Crowe | Christopher Matthews | I. Frazer | Richard D. Moore
[1] M. Puoti,et al. Mortality due to chronic viral liver disease among patients infected with human immunodeficiency virus. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] M C Weinstein,et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. , 2001, The New England journal of medicine.
[3] D. McCaffrey,et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. , 2001, The New England journal of medicine.
[4] Mari M. Kitahata,et al. Physician experience in the care of HIV-infected persons is associated with earlier adoption of new antiretroviral therapy. , 2000 .
[5] M Egger,et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. , 1999, JAMA.
[6] R. Chaisson,et al. Natural history of HIV infection in the era of combination antiretroviral therapy. , 1999, AIDS.
[7] Richard D Moore,et al. Costs of HIV medical care in the era of highly active antiretroviral therapy. , 1999, AIDS.
[8] D. McCaffrey,et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. , 1998, The New England journal of medicine.
[9] V. M. Shadle,et al. Self-reported antiretroviral therapy in injection drug users. , 1998, JAMA.
[10] B. Yip,et al. Barriers to use of free antiretroviral therapy in injection drug users. , 1998, JAMA.
[11] G. Satten,et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.
[12] R. A. Torres,et al. Impact of combination therapy for HIV infection on inpatient census. , 1997, The New England journal of medicine.
[13] R. Chaisson,et al. Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[14] N. Weiss,et al. HIV infection and vaginal douching in Central Africa , 1997, AIDS.
[15] T. Koepsell,et al. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. , 1996, The New England journal of medicine.
[16] F J Hellinger,et al. The lifetime cost of treating a person with HIV. , 1993, JAMA.
[17] P. Lee,et al. Medical care costs of patients with AIDS in San Francisco. , 1986, JAMA.